BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31243105)

  • 1. The Association of a Novel Identified
    Daremipouran MR; Beyene D; Apprey V; Naab TJ; Kassim OO; Copeland RL; Kanaan YM
    Cancer Genomics Proteomics; 2019; 16(4):245-255. PubMed ID: 31243105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association Between the Genetic
    Beyene DA; Daremipouran MR; Apprey V; Naab T; Kassim OO; Copeland RL; Kanaan YM
    Cancer Genomics Proteomics; 2020; 17(6):739-745. PubMed ID: 33099475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D receptor genetic polymorphisms are associated with PSA level, Gleason score and prostate cancer risk in African-American men.
    Jingwi EY; Abbas M; Ricks-Santi L; Winchester D; Beyene D; Day A; Naab TJ; Kassim OO; Dunston GM; Copeland RL; Kanaan YM
    Anticancer Res; 2015 Mar; 35(3):1549-58. PubMed ID: 25750310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.
    Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Kim D; Kim HJ; Myung SC
    Gene; 2014 Jan; 533(1):86-93. PubMed ID: 24120391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence variation within the 5' regulatory regions of the vitamin D binding protein and receptor genes and prostate cancer risk.
    Kidd LC; Paltoo DN; Wang S; Chen W; Akereyeni F; Isaacs W; Ahaghotu C; Kittles R
    Prostate; 2005 Aug; 64(3):272-82. PubMed ID: 15717311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study.
    Rowland GW; Schwartz GG; John EM; Ingles SA
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):16-24. PubMed ID: 23129590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
    Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHPLC Elution Patterns of
    Copeland RL; Beyene D; Apprey V; Daremipouran MR; Naab TJ; Kassim OO; Kanaan YM
    Cancer Genomics Proteomics; 2017; 14(6):461-467. PubMed ID: 29109096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women.
    Grant DJ; Hoyo C; Akushevich L; Iversen ES; Whitaker R; Marks J; Berchuck A; Schildkraut JM
    Gynecol Oncol; 2013 Apr; 129(1):173-8. PubMed ID: 23262379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor FokI gene polymorphisms may be associated with colorectal cancer among African American and Hispanic participants.
    Sarkissyan M; Wu Y; Chen Z; Mishra DK; Sarkissyan S; Giannikopoulos I; Vadgama JV
    Cancer; 2014 May; 120(9):1387-93. PubMed ID: 24510435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-control study of vitamin D, dickkopf homolog 1 (DKK1) gene methylation, VDR gene polymorphism and the risk of colon adenoma in African Americans.
    Ashktorab H; Nguza B; Fatemi M; Nouraie M; Smoot DT; Schäffer AA; Kupfer SS; Camargo CA; Brim H
    PLoS One; 2011; 6(10):e25314. PubMed ID: 22022386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D receptor polymorphisms and prostate cancer risk in Brazilian men.
    Maistro S; Snitcovsky I; Sarkis AS; da Silva IA; Brentani MM
    Int J Biol Markers; 2004; 19(3):245-9. PubMed ID: 15503828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between G/A1229, A/G3944, T/C30875, C/T48200 and C/T65013 genotypes and haplotypes in the vitamin D receptor gene, ultraviolet radiation and susceptibility to prostate cancer.
    Moon S; Holley S; Bodiwala D; Luscombe CJ; French ME; Liu S; Saxby MF; Jones PW; Fryer AA; Strange RC
    Ann Hum Genet; 2006 Mar; 70(Pt 2):226-36. PubMed ID: 16626332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.
    Ingles SA; Ross RK; Yu MC; Irvine RA; La Pera G; Haile RW; Coetzee GA
    J Natl Cancer Inst; 1997 Jan; 89(2):166-70. PubMed ID: 8998186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population.
    Suzuki K; Matsui H; Ohtake N; Nakata S; Takei T; Koike H; Nakazato H; Okugi H; Hasumi M; Fukabori Y; Kurokawa K; Yamanaka H
    Int J Urol; 2003 May; 10(5):261-6. PubMed ID: 12694466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium intake and prostate cancer among African Americans: effect modification by vitamin D receptor calcium absorption genotype.
    Rowland GW; Schwartz GG; John EM; Ingles SA
    J Bone Miner Res; 2012 Jan; 27(1):187-94. PubMed ID: 21887707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of vitamin D receptor and the risk of prostate cancer: a meta-analysis.
    Zhang Q; Shan Y
    J BUON; 2013; 18(4):961-9. PubMed ID: 24344024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
    PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.
    Grant DJ; Manichaikul A; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Funkhouser E; Moorman PG; Peres LC; Peters ES; Schwartz AG; Terry PD; Wang XQ; Keku TO; Hoyo C; Berchuck A; Sandler DP; Taylor JA; O'Brien KM; Velez Edwards DR; Edwards TL; Beeghly-Fadiel A; Wentzensen N; Pearce CL; Wu AH; Whittemore AS; McGuire V; Sieh W; Rothstein JH; Modugno F; Ness R; Moysich K; Rossing MA; Doherty JA; Sellers TA; Permuth-Way JB; Monteiro AN; Levine DA; Setiawan VW; Haiman CA; LeMarchand L; Wilkens LR; Karlan BY; Menon U; Ramus S; Gayther S; Gentry-Maharaj A; Terry KL; Cramer DW; Goode EL; Larson MC; Kaufmann SH; Cannioto R; Odunsi K; Etter JL; Huang RY; Bernardini MQ; Tone AA; May T; Goodman MT; Thompson PJ; Carney ME; Tworoger SS; Poole EM; Lambrechts D; Vergote I; Vanderstichele A; Van Nieuwenhuysen E; Anton-Culver H; Ziogas A; Brenton JD; Bjorge L; Salvensen HB; Kiemeney LA; Massuger LFAG; Pejovic T; Bruegl A; Moffitt M; Cook L; Le ND; Brooks-Wilson A; Kelemen LE; Pharoah PDP; Song H; Campbell I; Eccles D; DeFazio A; Kennedy CJ; Schildkraut JM
    Cancer Med; 2019 May; 8(5):2503-2513. PubMed ID: 31001917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
    Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.